(Q28196878)

Frans Van de Werf

10

0 references

Robert Califf

12

Robert M Califf

0 references

Erik Magnus Ohman

9

E Magnus Ohman

0 references

David J Moliterno

7

David J Moliterno

0 references

Robert A Harrington

3

Robert A Harrington

0 references

Peter B. Berger

6

Peter B Berger

0 references

Harvey D. White

8

Harvey D White

0 references

L Kristin Newby

2

L Kristin Newby

0 references

Manjushri V Bhapkar

4

Manjushri V Bhapkar

0 references

Freek W A Verheugt

5

Freek W A Verheugt

0 references

author name string

Thaddeus R Tolleson

American Journal of Cardiology

1

0 references

language of work or name

English

0 references

publication date

1 August 2003

0 references

published in

0 references

volume

92

0 references

issue

3

0 references

page(s)

330-3

0 references

cites work

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900641-6

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900641-6

Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900641-6

Subacute stent thrombosis: evolving issues and current concepts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900641-6

Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regime

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900641-6

Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900641-6

Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: study design of the sibrafiban versus aspirin to yield maximum protection from ischemic heart events post-acute coronary syndromes (SYM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900641-6

Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900641-6

Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900641-6

Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900641-6